Core concepts

Understand hemostasis as a system, not a list of factors

Coagulation becomes easier when you separate three questions: what happens in the vessel, what the laboratory measures, and how findings connect to the patient.

Your study

Understand → look up → apply

Step 1 of 3

Goal for this step

Understand the hemostasis sequence, distinguish the classic cascade from the cell-based model, and explain PT/aPTT logic without relying on memorized arrows.

Continue: Library

Six-step mental model

Use this sequence as your backbone, then return to factors and tests without memorizing isolated arrows.

Vascular injury

Local antithrombotic properties are disrupted and pro-hemostatic structures become exposed.

Platelet plug

vWF, collagen and platelet receptors drive adhesion, activation and aggregation.

Coagulation initiation

Tissue factor + FVIIa generate small amounts of Xa and thrombin.

Amplification

Early thrombin activates platelets and cofactors, preparing catalytic surfaces.

Thrombin burst

Tenase and prothrombinase on activated platelets generate large amounts of thrombin and fibrin.

Stabilization and control

FXIII strengthens fibrin while natural anticoagulants and fibrinolysis localize and later remove the clot.

Learn in layers

For every concept, look for four things: mechanism, clinical relevance, memory hook and common trap.

Before the cascade

Hemostasis overview

What happens

Primary hemostasis: vessel + von Willebrand factor + platelets form the initial plug.
Secondary hemostasis: plasma factors generate thrombin and fibrin to reinforce that plug.
Regulation: antithrombin, protein C/protein S and TFPI limit coagulation.
Fibrinolysis: plasmin degrades fibrin as repair progresses.

Why it matters

Mucocutaneous bleeding and petechiae point more toward primary hemostatic defects, whereas hemarthroses and deep hematomas suggest secondary hemostasis.

Memory hook

Think “plug first, reinforcement second”: platelets build the scaffold; fibrin adds strength.

Do not confuse

Hemostasis is not only the coagulation cascade. Platelets, endothelium, inhibitors and fibrinolysis all matter.

Classic cascade × cell-based model

Both are useful when applied to the right question.

Idea	Classic cascade	Cell-based model
Main question	Which factors does a screening assay explore?	How is coagulation organized in the body?
Central unit	Intrinsic, extrinsic and common pathways	Cell surfaces + initiation, amplification and propagation
Best use	Interpret PT/aPTT and localize defects	Understand thrombin, platelets and in-vivo pathophysiology
Limitation	Can look like a literal physiological sequence	More physiological, but does not replace routine assays

Quick PT/aPTT matrix

PT	aPTT	Think first about
↑	Normal	FVII, early vitamin K effect, early liver disease
Normal	↑	VIII, IX, XI, XII, heparin, lupus anticoagulant, inhibitor
↑	↑	X, V, II, fibrinogen, consumption, liver disease, anticoagulation
Normal	Normal	Platelets/vWF, FXIII or causes outside these tests

Conceptual basis

Use the classic cascade to organize laboratory testing and the cell-based model to understand in-vivo coagulation. Keeping those questions separate prevents a common learning error.

View scientific references

Open clinical library Apply it in the interactive lab